Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17131.08 -49.10 NIFTY 5090.55 -13.00
 

Nectar Lifesciences Cash Flow, Nectar Lifesciences Financial Statement & Accounts

Nectar Lifesciences

BSE: 532649  |  NSE: NECLIFE  |  ISIN: INE023H01027  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Cash Flow of Nectar Lifesciences

------------------- in Rs. Cr. -------------------
Mar '05 Mar '06 Mar '07 Mar '08 Mar '09
12 mths 12 mths 12 mths 12 mths 12 mths
Net Profit Before Tax 18.48 32.73 62.25 91.72 65.77
Net Cash From Operating Activities 0.06 -60.15 9.73 170.04 154.08
Net Cash (used in)/from
Investing Activities
-18.45 -47.18 -151.31 -115.64 -180.72
Net Cash (used in)/from Financing Activities 20.32 117.89 157.82 -64.14 35.29
Net (decrease)/increase In Cash and Cash Equivalents 1.93 10.56 16.24 -9.74 8.65
Opening Cash & Cash Equivalents 7.02 8.95 19.51 35.75 26.01
Closing Cash & Cash Equivalents 8.95 19.51 35.75 26.01 34.66
Source : Religare Technova
Explore Nectar Life connections